|
Search
Collections
Benchmarks
Upload document
Product
68Ga-NYM005
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 indication
Indication
Clear Cell Renal Cell Carcinoma
Clinical trial
Pharmacokinetics, Biodistribution, Radiation Dose and Safety Study of a Single Dose of Gallium [68Ga]-NYM005 Injection Prepared by Kit for the Preparation of the 68Ga-NYM005 Injection in Patients With Metastatic Clear Cell Renal Carcinoma.
Status: Recruiting
, Estimated PCD: 2024-12-01